Evista | Raloxifene Hydrochloride

1.1 Treatment and Prevention of Osteoporosis in Postmenopausal Women EVISTA is indicated for the treatment and prevention of osteoporosis in postmenopausal women. 1.2 Reduction in…


Cialis | Tadalafil

1.1 Erectile Dysfunction CIALIS® is indicated for the treatment of erectile dysfunction (ED). 1.2 Benign Prostatic Hyperplasia CIALIS is indicated for the treatment of the…


Effient | Prasugrel Hydrochloride

1.1 Acute Coronary Syndrome Effient® is indicated to reduce the rate of thrombotic cardiovascular (CV) events (including stent thrombosis) in patients with acute coronary syndrome…


Reopro | Abciximab

Abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergoing percutaneous coronary intervention in patients…


Lartruvo | Olaratumab

LARTRUVO™ is indicated, in combination with doxorubicin, for the treatment of adult patients with soft tissue sarcoma (STS) with a histologic subtype for which an…


Humatrope | Somatropin

1.1 Pediatric Patients Growth Hormone Deficiency — Humatrope is indicated for the treatment of pediatric patients who have growth failure due to inadequate secretion of…


Gemzar | Gemcitabine Hydrochloride

1.1 Ovarian Cancer Gemzar in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6…


Humalog | Insulin Lispro

HUMALOG is a rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. contraindications HUMALOG is contraindicated: during…


Alimta | Pemetrexed Disodium

1.1 Nonsquamous Non-Small Cell Lung Cancer – Combination with Cisplatin ALIMTA® is indicated in combination with cisplatin therapy for the initial treatment of patients with…


Cyramza | Ramucirumab

1.1 Gastric Cancer CYRAMZA® as a single agent, or in combination with paclitaxel, is indicated for the treatment of patients with advanced or metastatic, gastric…